Roche (RHHVF) News Today

Roche logo
$483.84 -3.66 (-0.75%)
As of 11/16/2026 03:37 PM Eastern

Roche Latest News

Roche Holding AG (RHHVF) was downgraded to a Hold Rating at UBS
Roche Holding AG (RHHVF) Receives a Buy from RBC Capital
Goldman Sachs Remains a Hold on Roche Holding AG (RHHVF)
Roche Holding AG (RHHVF) Gets a Hold from Berenberg Bank
Roche proposes former Takeda CEO for board seat
RBC Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Barclays Sticks to Their Buy Rating for Roche Holding AG (RHHVF)
Bernstein Remains a Buy on Roche Holding AG (RHHVF)
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion (RHHVF)
GSK agreed to acquire Nuvalent for $10.6 billion, or $124 per share, a roughly 40% premium, to add two late-stage lung cancer assets and offset an impending patent cliff.

Roche Media Mentions By Week

Roche Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RHHVF
News Sentiment
▼
0.00

0.59
▲
Average
Healthcare
News Sentiment

Roche News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RHHVF Articles
This Week
▼
1

1
▲
RHHVF Articles
Average Week

Roche Trends on MarketBeat

This week vs. last week
New Followers
1
Page Views
107
-52%
Get Roche News Delivered to You Automatically

Sign up to receive the latest news and ratings for RHHVF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Roche dated 11/16/2026.
From Our Partners